In vitro and in silico interactions of antiulcer, glucocorticoids and urological drugs on human carbonic anhydrase I and II isozymes.
drug-protein interaction
inhibition
isozyme purification
molecular docking
Journal
Biopharmaceutics & drug disposition
ISSN: 1099-081X
Titre abrégé: Biopharm Drug Dispos
Pays: England
ID NLM: 7911226
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
10
01
2022
received:
16
09
2021
accepted:
13
01
2022
pubmed:
27
1
2022
medline:
14
4
2022
entrez:
26
1
2022
Statut:
ppublish
Résumé
Carbonic anhydrases (CAs, Enzyme Commission 4.2.1.1) convert carbon dioxide to bicarbonate in metabolism and use Zn
Substances chimiques
Carbonic Anhydrase Inhibitors
0
Glucocorticoids
0
Isoenzymes
0
Budesonide
51333-22-3
Carbonic Anhydrase I
EC 4.2.1.-
Carbonic Anhydrase II
EC 4.2.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-56Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Akkemik, E., Taser, P., Bayindir, A., Budak, H., & Ciftci, M. (2012). Purification and characterization of glutathione S-transferase from Turkey liver and inhibition effects of some metal ions on enzyme activity. Environmental Toxicology and Pharmacology, 34(3), 888-894. https://doi.org/10.1016/j.etap.2012.08.010
Alım, Z., Köksal, Z., & Karaman, M. (2020). Evaluation of some thiophene-based sulfonamides as potent inhibitors of carbonic anhydrase I and II isoenzymes isolated from human erythrocytes by kinetic and molecular modelling studies. Pharmacological Reports, 72(6), 1738-1748.
Alterio, V., Di Fiore, A., D'Ambrosio, K., Supuran, C. T., & De Simone, G. (2012). Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chemical Reviews, 112(8), 4421-4468. https://doi.org/10.1021/cr200176r
Alterio, V., Monti, S. M., Truppo, E., Pedone, C., Supuran, C. T., & De Simone, G. (2010). The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: The carbonic anhydrase I-topiramate complex. Organic and Biomolecular Chemistry, 8(15), 3528-3533. https://doi.org/10.1039/b926832d
Angeli, A., Ferraroni, M., & Supuran, C. T. (2018). Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases. ACS Medicinal Chemistry Letters, 9(10), 1035-1038.
Argan, O., Çıkrıkçı, K., Baltacı, A., & Gencer, N. (2020). The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1359-1362.
Buzás, G. M., & Supuran, C. T. (2016). The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015). Journal of Enzyme Inhibition and Medicinal Chemistry, 31(4), 527-533.
Camadan, Y., Çiçek, B., Adem, Ş., Çalişir, Ü., & Akkemik, E. (2021). Investigation of in vitro and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II. Journal of Biomolecular Structure and Dynamics, 1-10.
Carta, F., & Supuran, C. T. (2013). Diuretics with carbonic anhydrase inhibitory action: A patent and literature review (2005-2013). Expert Opinion on Therapeutic Patents, 23(6), 681-691. https://doi.org/10.1517/13543776.2013.780598
Carter, M., & Parsons, D. (1971). The isoenzymes of carbonic anhydrase: Tissue, subcellular distribution and functional significance, with particular reference to the intestinal tract. The Journal of physiology, 215(1), 71-94.
Ekinci, D., Beydemir, S., & Alim, Z. (2007). Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacological Reports, 59(5), 580.
El-Hachem, N., Haibe-Kains, B., Khalil, A., Kobeissy, F. H., & Nemer, G. (2017). AutoDock and AutoDockTools for protein-ligand docking: Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a case study. In:Neuroproteomics (pp. 391-403). Springer.
Güller, P., Dağalan, Z., Güller, U., Çalışır, U., & Nişancı, B. (2021). Enzymes inhibition profiles and antibacterial activities of benzylidenemalononitrile derivatives. Journal of Molecular Structure, 1239, 130498.
Henry, E. K., Sy, C. B., Inclan-Rico, J. M., Espinosa, V., Ghanny, S. S., Dwyer, D. F., Soteropoulos, P., Rivera, A., & Siracusa, M. C. (2016). Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. Journal of Experimental Medicine, 213(9), 1663-1673. https://doi.org/10.1084/jem.20151739
Innocenti, A., Vullo, D., Scozzafava, A., & Supuran, C. T. (2005). Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate. Bioorganic & Medicinal Chemistry Letters, 15(3), 567-571. https://doi.org/10.1016/j.bmcl.2004.11.056
Jensen, E. L., Clement, R., Kosta, A., Maberly, S. C., & Gontero, B. (2019). A new widespread subclass of carbonic anhydrase in marine phytoplankton. The ISME Journal, 13(8), 2094-2106.
Jones, G. L., & Shaw, D. C. (1982). Purification, properties, partial sequence and evolutionary relationships of marsupial erythrocyte carbonic-anhydrase. Biochimica et Biophysica Acta, 709(2), 284-303. https://doi.org/10.1016/0167-4838(82)90471-X
Kaplan, S. T., Kuzucu, M., Aktaş, N., Dilek, E., Çankaya, M., & Çoban, T. A. (2017). Investigation effects of some heart disorder drugs on human carbonic anhydrase I. Hacettepe Journal of Biology and Chemistry, 45(2), 231-236.
Karhumaa, P., Leinonen, J., Parkkila, S., Kaunisto, K., Tapanainen, J., & Rajaniemi, H. (2001). The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proceedings of the National Academy of Sciences, 98(20), 11604-11608.
Keha, E. E., & Küfrevioğlu, Ö. İ. (2019). Biyokimya: [in Turkish]. Aktif Yayın Dağıtım.
Kılınç, N., Alım, Z., Şengül, B., İşgör, M. M., & Beydemir, Ş. (2018). Evaluation of inhibition effects of some cardiovascular therapeutics on human erythrocyte carbonic anhydrase isoenzymes. Bitlis Eren Üniversitesi Fen Bilimleri Dergisi, 7(1), 90-97.
Laemelli, D. (1970). Cleavage of structural proteins during in assembly of the head of bacteriophage. Nature, 227-680.
Lönnerholm, G., Selking, Ö., & Wistrand, P. J. (1985). Amount and distribution of carbonic anhydrases CA I and CA II in the gastrointestinal tract. Gastroenterology, 88(5), 1151-1161.
Lopez, M., Paul, B., Hofmann, A., Morizzi, J., Wu, Q. K., Charman, S. A., Innocenti, A., Vullo, D., Supuran, C. T., & Poulsen, S.-A. (2009). S-glycosyl primary sulfonamides − A new structural class for selective inhibition of cancer-associated carbonic anhydrases. Journal of Medicinal Chemistry, 52(20), 6421-6432.
Maren, T. H. (1988). The kinetics of HCO3 − Synthesis related to fluid secretion, pH control, and CO2 elimination. Annual Review of Physiology, 50(1), 695-717.
Masini, E., Carta, F., Scozzafava, A., & Supuran, C. T. (2013). Antiglaucoma carbonic anhydrase inhibitors: A patent review. Expert Opinion on Therapeutic Patents, 23(6), 705-716.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785-2791. https://doi.org/10.1002/jcc.21256
Nalbantoğlu, B., Demir, N., Özdemir, H., & Küfrevioğlu, Ö. İ. (1996). A new method for the purification of carbonic anhydrase isozymes by affinity chromatography. Turkish Journal of Medical Sciences, 21, 159-162.
Nelson, D. L., Lehninger, A. L., & Cox, M. M. (2008). Lehninger principles of biochemistry. Macmillan.
Neri, D., & Supuran, C. T. (2011). Interfering with pH regulation in tumours as a therapeutic strategy. Nature Reviews Drug Discovery, 10(10), 767-777. https://doi.org/10.1038/nrd3554
O'Connor, B., Yeo, C., Chen-Worsdell, Y., Barnes, P., & Chung, K. (1994). Effect of acetazolamide and amiloride against sodium metabisulphite-induced bronchoconstriction in mild asthma. Thorax, 49(11), 1096-1098.
O'Donnell, W. J., Rosenberg, M., Niven, R. W., Drazen, J. M., & Israel, E. (1992). Acetazolamide and furosemide attenuate asthma induced by hyperventilation of cold, dry air. American Review of Respiratory Disease, 146(6), 1518-1523.
Sağlık, B. N., Cevik, U. A., Osmaniye, D., Levent, S., Çavuşoğlu, B. K., Demir, Y., Ilgın, S., Özkay, Y., Koparal, A. S., Beydemir, Ş., & Kaplancıklı, Z. A. (2019). Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic Chemistry, 91.103153.
Sakurai, K., Nagahara, A., Inoue, K., Akiyama, J., Mabe, K., Suzuki, J., Habu, Y., Araki, A., Suzuki, T., Satoh, K., Nagami, H., Harada, R., Tano, N., Kusaka, M., Fujioka, Y., Fujimura, T., Shigeto, N., Oumi, T., Miwa, J., … Haruma, K. (2012). Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: An omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterology, 12(1), 1-12.
Scozzafava, A., Supuran, C. T., & Carta, F. (2013). Antiobesity carbonic anhydrase inhibitors: A literature and patent review. Expert Opinion on Therapeutic Patents, 23(6), 725-735.
Shabana, A. M., Mondal, U. K., Alam, M. R., Spoon, T., Ross, C. A., Madesh, M., Supuran, C. T., & Ilies, M. A. (2018). pH-sensitive multiligand gold nanoplatform targeting carbonic anhydrase IX enhances the delivery of doxorubicin to hypoxic tumor spheroids and overcomes the hypoxia-induced chemoresistance. Acs Applied Materials & Interfaces, 10(21), 17792-17808. https://doi.org/10.1021/acsami.8b05607
Shivanika, C., Kumar, D., Ragunathan, V., Tiwari, P., & Sumitha, A. (2020). Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease. Journal of biomolecular structure & dynamics, 1.
Sly, W. S., & Hu, P. Y. (1995). Human carbonic anhydrases and carbonic anhydrase deficiencies. Annual Review of Biochemistry, 64(1), 375-401.
Spicuzza, L., Ciancio, N., Pellegrino, R., Bellofiore, S., Polosa, R., Ricciardolo, F. L. M., Brusasco, V., & Di Maria, G. (2003). The effect of inhaled furosemide and acetazolamide on bronchoconstriction induced by deep inspiration in asthma. Monaldi Archives for Chest Disease, 59(2), 150-154.
Supuran, C. T. (2008). Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery, 7(2), 168-181. https://doi.org/10.1038/nrd2467
Supuran, C. T. (2012). Structure-based drug discovery of carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(6), 759-772.
Supuran, C. T. (2016). How many carbonic anhydrase inhibition mechanisms exist? Journal of Enzyme Inhibition and Medicinal Chemistry, 31(3), 345-360.
Supuran, C. T. (2017). Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opinion on Drug Discovery, 12(1), 61-88.
Supuran, C. T. (2018). Carbonic anhydrases and metabolism. Metabolites, 8(2), 25.
Supuran, C. T., Scozzafava, A., & Casini, A. (2003). Carbonic anhydrase inhibitors. Medicinal Research Reviews, 23(2), 146-189.
Türkeş, C., Demir, Y., & Beydemir, Ş. (2021). Calcium channel blockers: Molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes. Journal of Biomolecular Structure and Dynamics, 39(5), 1672-1680.
Uzunoglu, S. B., Yalcin, Y., Uzunoglu, T., Karadeniz, S., & Kurt, H. (2020). Preparing and optimizing a newly affinity gel for purification of carbonic anhydrase isoenzymes. FEB FRESENIUS ENVIRONMENTAL BULLETIN, 3798.
Verpoorte, J. A., Mehta, S., & Edsall, J. T. (1967). Esterase activities of human carbonic anhydrases B and C. Journal of Biological Chemistry, 242, 4221-4229.
Wang, A. L., Panganiban, R., Qiu, W., Kho, A. T., Chupp, G., Meyers, D. A., Bleecker, E. R., Tantisira, K. G., Weiss, S. T., Lu, Q., & Tantisira, K. G. (2021). Drug repurposing to treat glucocorticoid resistance in asthma. Journal of Personalized Medicine, 11(3), 175.
Wilbur, K. M., & Anderson, N. G. (1948). Electrometric and colorimetric determination of carbonic anhydrase. Journal of Biological Chemistry, 176(1), 147-154.